DGRO may stand out for investors looking for an ETF focused not only on the highest dividend yields, but on quality dividend payers likely to be stable.
NORTH CHICAGO, Ill. , March 9, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results 1 from the multiple ascending dose (MAD) part of its Phase 1 study evaluating...
1 Momentum Stock to Consider Right Now and 2 We Ignore
Three companies with a combination of excellent name recognition within their industries and strong free cash flow potential provide a stable investment option.
AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?
Data shows a rise in specific treatment demand; a shift in patient consultation and the rising role of facial volume restoration
NORTH CHICAGO, Ill. , March 3, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026. Management will participate...
NORTH CHICAGO, Ill. , March 2, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating...
/Abbvie%20Inc%20billboard%20-by%20Poetra_%20RH%20via%20Shutterstock.jpg)
Although AbbVie has lagged behind the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
NORTH CHICAGO, Ill. , Feb. 24, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate...